Annual Meeting Archives
2016
Category:
Comparative Pharmacokinetics in Preclinical Sciences
Institutions:
(1) University of California at San Diego, U.S.A.
Category:
Local Drug Delivery
Institutions:
(1) University of Pittsburgh, U.S.A.
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Aston University, United Kingdom
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) University of BC, Canada
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Institutions:
(1) Korea Institute of Science and Technology, South Korea; (2) Korea Institute of Science and Technology & Korea University, South Korea; (3) Korea Institute of Science and Technology & Seoul National University, South Korea
Category:
Oral Delivery
Institutions:
(1) University of Maryland, Baltimore, U.S.A.; (2) SE Tylose USA, Inc., U.S.A.
Category:
Oral Delivery
Institutions:
(1) US FDA, U.S.A.
Category:
Local Drug Delivery
Institutions:
(1) Department of Pharmacy, Central University of Rajasthan, India; (2) Central University of Rajasthan, India
Category:
Oral Delivery
Institutions:
(1) Keck Graduate Institute, U.S.A.; (2) Keck Sciences Department of Claremont McKenna, Pitzer, and Scripps Colleges, U.S.A.
Category:
New Processes, New Materials, New Products
Institutions:
(1) University of South Australia, Australia
Category:
Oral Delivery
Institutions:
(1) School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Category:
Oral Delivery
Institutions:
(1) Bayer HealthCare LLC, U.S.A.
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Teikyo University, Japan
Category:
Oral Delivery
Institutions:
(1) BIAL - Portela & Cª., S.A., Portugal
Category:
Transdermal Delivery
Institutions:
(1) Aston University, United Kingdom
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Purdue University, U.S.A.
Category:
Oral Delivery
Institutions:
(1) University of Maryland Baltimore, U.S.A.
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Institutions:
(1) Samyang Biopharmaceuticals Corporation, Korea
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Category:
Local Drug Delivery
Institutions:
(1) PATH, U.S.A.
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) Biopharmaceutics, Pharmaceutical Sciences and Clinical Supply, Merck & Co., U.S.A.; (2) Division of Pharmaceutical Sciences, Long Island University, U.S.A.
Category:
Local Drug Delivery
Institutions:
(1) University of New Mexico College of Pharmacy, U.S.A.
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Ira, Iran; (2) Ardebil University of medical science, Ardebil, Iran, Iran
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) Tokyo University of Agriculture and Technology, Japan
Category:
Transdermal Delivery
Institutions:
(1) Toppan Printing Co., LTD., Japan; (2) National Institute of Infectious Diseases, Japan